These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25702399)

  • 1. [Effect of dosage forms loop diuretic with a different release rate for early and delayed the prognosis of patients with circulatory decompensation].
    Arutiunov AG; Dragunov DO; Arutiunov GP; Rylova AK; Sokolova AV
    Kardiologiia; 2014; 54(9):24-32. PubMed ID: 25702399
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action.
    Shah S; Pitt B; Brater DC; Feig PU; Shen W; Khwaja FS; Wilcox CS
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ways of optimizing diuretic therapy in congestive heart failure, chronic place torasemide prolonged release].
    Kobalava ZhD; Kiiakbaev GK
    Kardiologiia; 2014; 54(4):69-77. PubMed ID: 25177788
    [No Abstract]   [Full Text] [Related]  

  • 4. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
    Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
    Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
    Ballester MR; Roig E; Gich I; Puntes M; Delgadillo J; Santos B; Antonijoan RM
    Drug Des Devel Ther; 2015; 9():4291-302. PubMed ID: 26273191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
    Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
    Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
    Mentz RJ; Buggey J; Fiuzat M; Ersbøll MK; Schulte PJ; DeVore AD; Eisenstein EL; Anstrom KJ; OʼConnor CM; Velazquez EJ
    J Cardiovasc Pharmacol; 2015 May; 65(5):438-43. PubMed ID: 25945862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacodynamics of torsemide in patients with congestive heart failure.
    Vargo D; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):48-54. PubMed ID: 8033494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Loop diuretics: old and new ones--which one to choose in clinical practice? Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure].
    Mamcarz A; Filipiak KJ; Drożdż J; Nessler J; Tykarski A; Niemczyk M; Wożakowska-Kapłon B
    Kardiol Pol; 2015; 73(3):225-32. PubMed ID: 25791979
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Oyama MA; Peddle GD; Reynolds CA; Singletary GE
    J Vet Cardiol; 2011 Dec; 13(4):287-92. PubMed ID: 22030290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?
    De Vecchis R; Ciccarelli A; Pucciarelli A
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):571-4. PubMed ID: 20588135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should torsemide be the loop diuretic of choice in systolic heart failure?
    DiNicolantonio JJ
    Future Cardiol; 2012 Sep; 8(5):707-28. PubMed ID: 23013124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
    Verbrugge FH; Martens P; Boonen L; Nijst P; Verhaert D; Noyens P; De Vusser P; Dupont M; Tang WHW; Mullens W
    Acta Cardiol; 2018 Aug; 73(4):335-341. PubMed ID: 28971753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?
    Bikdeli B; Strait KM; Dharmarajan K; Partovian C; Coca SG; Kim N; Li SX; Testani JM; Khan U; Krumholz HM
    J Am Coll Cardiol; 2013 Apr; 61(14):1549-50. PubMed ID: 23500272
    [No Abstract]   [Full Text] [Related]  

  • 16. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction.
    Galve E; Mallol A; Catalan R; Palet J; Méndez S; Nieto E; Diaz A; Soler-Soler J
    Eur J Heart Fail; 2005 Aug; 7(5):892-8. PubMed ID: 16087141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
    Ter Maaten JM; Rao VS; Hanberg JS; Perry Wilson F; Bellumkonda L; Assefa M; Sam Broughton J; D'Ambrosi J; Wilson Tang WH; Damman K; Voors AA; Ellison DH; Testani JM
    Eur J Heart Fail; 2017 Aug; 19(8):1014-1022. PubMed ID: 28105769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
    Miles JA; Hanumanthu BK; Patel K; Chen M; Siegel RM; Kokkinidis DG
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):379-388. PubMed ID: 30950982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
    Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
    J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.